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A major characteristic of Candida biofilm cells that differentiates them from free-floating 
cells is their high tolerance to antifungal drugs. This high resistance is attributed to particular 
biofilm properties, including the accumulation of extrapolymeric substances, morphogenetic 
switching, and metabolic flexibility. 
 
Objectives 
This study evaluated the roles of metabolic processes (in particular the glyoxylate cycle) on 
biofilm formation, antifungal drug resistance, morphology, and cell wall components. 
 
Methods 
Growth, adhesion, biofilm formation, and cell wall carbohydrate composition were quantified 
for isogenic Candida albicans ICL1/ICL1, ICL1/icl1, and icl1/icl1 strains. The morphology 
and topography of these strains were compared by light microscopy and scanning electron 
microscopy. FKS1 (glucan synthase), ERG11 (14-α-demethylase), and CDR2 (efflux pump) 
mRNA levels were quantified using qRT-PCR. 
 
Results 
The ICL1/icl1 and icl1/icl1 strains formed similar biofilms and exhibited analogous drug-
tolerance levels to the control ICL1/ICL1 strains. Furthermore, the drug sequestration ability 
of β-1, 3-glucan, a major carbohydrate component of the extracellular matrix, was not 
impaired. However, the inactivation of ICL1 did impair morphogenesis. ICL1 deletion also 
had a considerable effect on the expression of the FKS1, ERG11, and CDR2 genes. FKS1 
and ERG11 were upregulated in ICL1/icl1 and icl1/icl1 cells throughout the biofilm 
developmental stages, and CDR2 was upregulated at the early phase. However, their 
expression was downregulated compared to the control ICL1/ICL1 strain. 
 
Conclusions 
We conclude that the glyoxylate cycle is not a specific determinant of biofilm drug 
resistance. 
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